drugset / Trial / NCT05746143

The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

NCT05746143

Phase 4 Recruiting 140 enrolled University of Southern California
RandomizedParallel-groupTriple-blindSupportive care

Summary

The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.

Timeline

Start
2022-02-01
Primary completion
2029-01-31
Completion
2030-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 10 mg